Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib.

about

Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib.

Item

http://www.wikidata.org/entity/Q38671842

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pulmonary arterial hypertensio ...... cted side effect of sunitinib.

@en

type

Item

label

Pulmonary arterial hypertensio ...... cted side effect of sunitinib.

@en

prefLabel

Pulmonary arterial hypertensio ...... cted side effect of sunitinib.

@en

P1476

Pulmonary arterial hypertensio ...... cted side effect of sunitinib.

@en

P2093

Amaury Daste

http://www.w3.org/2001/XMLSchema#string

Louis François

http://www.w3.org/2001/XMLSchema#string

Marine Gross-Goupil

http://www.w3.org/2001/XMLSchema#string

Marion Laine

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Normalization of the vasculature for treatment of cancer and other diseases.

Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma

Mechanisms of adverse effects of anti-VEGF therapy for cancer.

Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma

Thrombotic events in patients with cancer receiving antiangiogenesis agents.

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.

Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis.

Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma.

P304

1219-1221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2017-0012

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alain Ravaud

Jean-Christophe Bernhard

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28606002

http://www.w3.org/2001/XMLSchema#string